ECKERT LIFE SCIENCE ACCELERATOR
Eckert Life Science Accelerator is an incubator for life science from Berlin in Germany. It invests primarily in start-up companies who are in need of first-round venture capital financing and actively supports them during the transformation process from start-ups into mature and valuable companies. It is a spin-off of Eckert Wagniskapital und Frรผhphasenfinanzierung.
ECKERT LIFE SCIENCE ACCELERATOR
Industry:
Angel Investment Biotechnology Financial Services Impact Investing Life Science
Status:
Active
Contact:
+49 30 941 084-453
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Organization Schema Typekit LocalBusiness Schema
Similar Organizations
University of Tuebingen
Tuebingen University is a German public research university.
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2020-02-06 | Pentixapharm | Eckert Life Science Accelerator investment in Series A - Pentixapharm | 15 M EUR |
More informations about "Eckert Life Science Accelerator"
Team - ELSA
Dr. Andreas Eckert. Founder and Managing Partner . Dr. Sven-Peter Heyn. Operations . Phillip Eckert. Portfolio Manager . Henner Kollenberg. Strategy . Benedikt Middelstaedt. Business โฆSee details»
Eckert Life Science Accelerator - Crunchbase
Eckert Life Science Accelerator is an incubator for life science from Berlin in Germany. It invests primarily in start-up companies who are in need of first-round venture capital financing and actively supports them during the transformation โฆSee details»
Eckert Life Science Accelerator - EU-Startups
Eckert Life Science Accelerator is an incubator for life science from Berlin in Germany. ELSA invests primarily in biotech, pharmaceutical, or medtech start-ups who are in need of seed or A-round venture capital financing. It actively โฆSee details»
Eckert Life Science Accelerator investment portfolio | PitchBook
Feb 14, 2020 Eckert Life Science Accelerator's latest investment was on 11-Jul-2023 in Cellsense Technologies, a company within the Discovery Tools (Healthcare) industry. Data โฆSee details»
Portfolio โ ELSA
ELSA manages a diversified portfolio of multiple investments in the life sciences industry. In total, the portfolio contains a number of compounds in varying development stages, all of which target multi-billion-Euro markets in the life โฆSee details»
Eckert Life Science Accelerator - CB Insights
Jun 29, 2020 Eckert Life Science Accelerator (ELSA), a spin-off of Eckert Wagniskapital und Fruhphasenfinanzierung, is a Berlin-based life science incubator with over two decades of โฆSee details»
Eckert Life Science Accelerator - Business Information - ZoomInfo
Eckert Life Science Accelerator - Business Information. Business Services · Germany · <25 Employees. Eckert Life Science Accelerator (ELSA), a spin-off of Eckert Wagniskapital und โฆSee details»
Eckert Life Science Accelerator - Crunchbase
Eckert Life Science Accelerator is an incubator for life science from Berlin in Germany. Search Crunchbase. Start Free Trial . ... Eckert Life Science Accelerator has invested in Pentixapharm โฆSee details»
Eckert Life Science Accelerator - Investor Profile, Portfolio ... - Tracxn
Eckert Life Science Accelerator - Venture capital firm investing in biotech, pharmaceutical, or medtech start-ups. Portfolio of 15 companies. 3 investors have invested with Eckert Life โฆSee details»
Eckert Life Science Accelerator - Contacts, Employees
Eckert Life Science Accelerator is an incubator for life science from Berlin in Germany. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. โฆSee details»
Contact - ELSA
ELSA Eckert Life Science Accelerator GmbH Robert-Rössle-Straße 10 13125 Berlin, Germany . Phillip Eckert [email protected] Tel.: +49 30 941 084-227 Fax: +49 30 941 084-112. โฆSee details»
PENTIXAPHARM Secures โฌ 15 Million Series A Financing to โฆ
Feb 6, 2020 (Only Available in English) Funding will be used for phase I / phase II trials of the lead program PentixaTher/ PentixaFor. Würzburg (Germany), February 6th, 2020 โ โฆSee details»
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of โฆ
5 days ago SAN DIEGO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (โMaravaiโ or the โCompanyโ) (NASDAQ: MRVI), a global provider of life science โฆSee details»
The long and winding road in drug development: Learnings from โฆ
May 25, 2020 Eckert Life Science Accelerator and Investment Bank Berlin. Metrics & Citations Metrics. Altmetric Citations Article Citation Dirk Pleimes et al., The long and winding road in โฆSee details»
PENTIXAPHARM Secures โฌ 15 Million Series A Financing - Scintomics
Feburary 6th 2020, WÜRZBURG, Germany--PentixaPharm announced today to have secured โฌ 15 million in a series A financing round led by ELSA Eckert Life Science Accelerator. โฆSee details»
News - ELSA
ELSA Eckert Life Science Accelerator Robert-Rössle-Str. 10 13125 Berlin. Contact Zurück zum Seitenanfang. Imprint/Data Protection ...See details»
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of โฆ
5 days ago SAN DIEGO, Dec. 05, 2024 -- Maravai LifeSciences Holdings, Inc. , a global provider of life science reagents and services to researchers and biotech innovators, announced that โฆSee details»
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman
5 days ago About R. Andrew Eckert Mr. Eckert is a Senior Adviser to Permira, a global private equity leader. Prior to Permira, he served as CEO of Zelis, a healthcare payments and cost โฆSee details»